Search
for
Sort by
Research 30 of 252
- LUPUS ERYTHEMATOSUS AND THE SKIN
- Selective Sensing of Darolutamide and Thalidomide in Pharmaceutical Preparations and in Spiked Biofluids
- Tumor necrosis factor inhibitors and janus kinase inhibitors in the treatment of cicatricial alopecia: A systematic review
- Cutaneous Manifestations of Lupus Erythematosus
- The Itchy Scalp
- Cutaneous Involvement in Systemic Lupus Erythematosus: A Review for the Rheumatologist
- Recent Insight on the Management of Lupus Erythematosus Alopecia
- Repositioning Old Drugs for New Battles: The Expanding Role of Drug Repurposing in Cancer, Inflammation, and Metabolic Disease.
- Dermatologic therapy: December 1987 to December 1988
- Recent Insights in Multi‐Target Drugs in Pharmacology and Medicinal Chemistry
- Drug repurposing: Clinical practices and regulatory pathways
- Mast Cells and Scarring Alopecia: Is There a Clear Pathophysiological Relationship?
- Drug repositioning using <i>in silico</i> compound profiling
- Tumour regression predicts higher risk of sentinel node involvement in thin cutaneous melanomas
- Medication-Induced Repigmentation of Gray Hair: A Systematic Review
- Cutaneous adverse reactions linked to targeted anticancer therapies bortezomib and lenalidomide for multiple myeloma: new drugs, old side effects
- Cutaneous drug reactions
- Benign Cutaneous Eruptions After Transplantation
- 13. Wound Healing & Hair
- 4. Bullous/Mucous Membrane
- An Overview of Alopecias
- Update on the dermatologic use of systemic glucocorticosteroids
- Secondary cicatricial and other permanent alopecias
- Drug Repositioning: New Opportunities for Older Drugs
- Acne and acneiform eruptions
- Computational Evaluation of Dibenzo Compounds as Potential Dual Inhibitors of Androgen Receptor and 5α-Reductase
- Index
- Non-Neoplastic Disorders of Hair
- The British Society for Rheumatology guideline for the management of systemic lupus erythematosus in adults
- What causes hidradenitis suppurativa ?—15 years after